- NCT Number Not Available
- Primary Citation
You are not logged in.
Please login to continue selecting trials.
Generic NameTopiramateProduct NameTOPAMAX®Therapeutic AreaNervous System DiseasesEnrollment% Female45%% White91%
Product ClassAnticonvulsantsSponsor Protocol NumberYPData PartnerJohnson & JohnsonCondition StudiedSeizuresMean/Median Age (Years)9
- Collected Datasets Available
- Data Definition Specification Available
- Protocol with Amendments Available
- Statistical Analysis Plan Available
- Clinical Study Report Available
Approved Data Requests Associated with this Trial
- Add-on treatment for refractory focal-onset epilepsy: Individual Participant Data Network Meta-Analysis
- Psychiatric Symptoms as Adverse Events of Topiramate Therapy: Systematic Review and Meta-Analysis
- Machine Learning for predicting treatment efficacy and clinical categorizations across mental health disorders.